￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Guide to the official purchasing channels of Gefapixant Citrate

2026-02-01 22:25:32

Check Details
Analysis of pharmacodynamic characteristics and clinical functions of Stiripentol

2026-02-01 22:25:32

Check Details
Indian version of Futibatinib price and channels

2026-02-01 22:25:32

Check Details
What is the national unified retail price of ensifentrine-Ohtuvayre?

2026-02-01 22:25:32

Check Details
The balance of effects and side effects of pyrotinib/arini

2026-02-01 22:25:32

Check Details
Introduction to the classification of which type of drugs Fulvestrant/Fuxit belongs to

2026-02-01 22:25:32

Check Details
Interpretation of the international phase III data of Gefapixant Citrate

2026-02-01 22:25:32

Check Details
Analysis of the reasons why some countries have banned the sale of Stiripentol

2026-02-01 22:25:32

Check Details
Evaluation of the therapeutic effect of Futibatinib on cholangiocarcinoma

2026-02-01 22:25:32

Check Details
Axitinib medical insurance reimbursement conditions and patient application process for medical insurance

2026-02-01 22:25:32

Check Details
What is the therapeutic effect of Trametinib (Megenin) and comparison of the efficacy in different patients

2026-02-01 22:25:32

Check Details
Treatment plan for ineffective treatment of avatrombopag (Sucoxin) after taking it for 10 days

2026-02-01 22:25:32

Check Details
Category
相关知识